Qualigen Therapeutics, Inc.
QLGN
$5.23
-$0.36-6.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 331.60K | 30.20K | 1.17M | 388.20K | 118.70K |
| Total Receivables | 3.31M | 2.23M | 2.01M | 1.30M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 276.50K | 512.60K | 1.50M | 626.80K | 415.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 40.00K | 73.20K | -- | -- | -- |
| Total Current Assets | 3.96M | 2.85M | 4.68M | 2.31M | 534.40K |
|
|
|||||
| Total Current Assets | 3.96M | 2.85M | 4.68M | 2.31M | 534.40K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.00K | 2.00K | 2.00K | -- | -- |
| Total Assets | 3.96M | 2.85M | 4.69M | 2.31M | 534.40K |
|
|
|||||
| Total Accounts Payable | 1.40M | 1.53M | 1.57M | 1.64M | 1.85M |
| Total Accrued Expenses | 379.60K | 210.10K | 170.20K | 562.90K | 929.10K |
| Short-term Debt | 3.62M | 843.60K | -- | 1.43M | 1.67M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 214.00K | 230.00K | 269.20K | 818.30K | 359.30K |
| Total Other Current Liabilities | 214.00K | 230.00K | 269.20K | 818.30K | 359.30K |
| Total Current Liabilities | 5.62M | 2.81M | 2.01M | 4.45M | 4.81M |
|
|
|||||
| Total Current Liabilities | 5.62M | 2.81M | 2.01M | 4.45M | 4.81M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 3.62M | 843.60K | -- | 1.43M | 1.67M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.62M | 2.81M | 2.01M | 4.45M | 4.81M |
|
|
|||||
| Common Stock & APIC | 122.95M | 122.92M | 120.02M | 120.06M | 116.13M |
| Retained Earnings | -127.39M | -125.71M | -123.06M | -122.21M | -120.41M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4.44M | -2.79M | -3.04M | -2.14M | -4.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | 5.72M | -- | -- |
| Preferred Stock Convertible | 2.79M | 2.82M | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.79M | 2.82M | 5.72M | -- | -- |
|
|
|||||
| Total Common Equity | -4.44M | -2.79M | -3.04M | -2.14M | -4.28M |
| Total Preferred Equity | 2.79M | 2.82M | 5.72M | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.65M | 33.10K | 2.68M | -2.14M | -4.28M |
|
|
|||||